Noumi Limited Reports FY26 Revenue Growth and Higher EBITDA Outlook
Noumi Limited (ASX: NOU) reported Q4 FY26 revenue of AU$158.6 million, up 2.2% year-on-year, supported by growth across its Plant-based Milks, Dairy and Nutritionals segments. Plant-based Milks revenue increased 1.9% to AU$47.0 million, while Dairy and Nutritionals revenue rose 2.2% to AU$111.7 million. Domestic Milklab retail sales and contract manufacturing delivered strong growth, while Consumer Nutritionals and Nutritional Ingredients also performed positively. The company generated AU$15.1 million in operating cash inflow during the quarter and ended FY26 with AU$15.3 million in unrestricted cash and AU$10.0 million in undrawn facilities. Noumi expects FY26 adjusted operating EBITDA of approximately AU$61 million to AU$63 million, compared with AU$57.4 million in FY25. However, management remains cautious about input costs, commodity prices, competition and AUD strength heading into FY27.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Noumi Limited Reports FY26 Revenue Growth and Higher EBITDA Outlook
Noumi Limited (ASX: NOU) reported Q4 FY26 revenue of AU$158.6 million, up 2.2% year-on-year, supported by growth across its Plant-based Milks, Dairy and Nutritionals segments. Plant-based Milks revenue increased 1.9% to AU$47.0 million, while Dairy and Nutritionals revenue rose 2.2% to AU$111.7 million. Domestic Milklab retail sales and contract manufacturing delivered strong growth, while Consumer Nutritionals and Nutritional Ingredients also performed positively. The company generated AU$15.1 million in operating cash inflow during the quarter and ended FY26 with AU$15.3 million in unrestricted cash and AU$10.0 million in undrawn facilities. Noumi expects FY26 adjusted operating EBITDA of approximately AU$61 million to AU$63 million, compared with AU$57.4 million in FY25. However, management remains cautious about input costs, commodity prices, competition and AUD strength heading into FY27.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au